Analytic and dynamic secretory profile of patient-derived cytokine-induced killer cells

Giulia Mesiano, Roberta Zini, Giulia Montagner, Nicoletta Bianchi, Rossella Manfredini, Antonella Chillemi, Massimo Aglietta, Giovanni Grignani, Ilaria Lampronti, Erika Fiorino, Fabio Malavasi, Dario Sangiolo, Roberto Gambari, Davide Ferrari

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Adoptive immunotherapy with cytokine induced killer (CIK) cells has shown antitumor activity against several kinds of cancer in preclinical models and clinical trials. CIK cells are a subset of ex vivo expanded T lymphocytes with T-NK phenotype and MHC-unrestricted antitumor activity. The literature provides scant information on cytokines, chemokines and growth factors secreted by CIK cells. Therefore, we investigated the secretory profile of CIK cells generated from tumor patients. The secretome analysis was performed at specific time points (d 1, d 14 and d 21) of CIK cell expansion. Mature CIK cells (d 21) produce a great variety of interleukins and secreted proteins that can be divided into three groups based on their secretion quantity: high (interleukin [IL]-13, regulated on activation normal T cell expressed and secreted [RANTES] chemokine, MIP-1α and 1β), medium (IL-1Ra, IL-5, IL-8, IL-10, IL-17, IP-10, INF-γ, vascular endothelial growth factor [VEGF] and granulocyte-macrophage colony-stimulating factor [GM-CSF]) and low (IL-1β, IL-4, IL-6, IL-7, IL-9, IL-12, IL-15, eotaxin, platelet-derived growth factor-bb, basic fibroblast growth factor, G-CSF and monocyte chemoattractant protein [MCP]-1). Moreover, comparing peripheral blood mononuclear cells (PBMCs) (d 1) and mature CIK cells (d 14 and 21) secretomes, we observed that IL-5, IL-10, IL-13, GM-CSF and VEGF were greatly upregulated, while IL-1β, IL-6, IL-8, IL-15, IL-17, eotaxin, MCP-1 and RANTES were downregulated. We also performed a gene expression profile analysis of patient-derived CIK cells, showing that mRNA for the different cytokines and secreted proteins was modulated during PBMC-to-CIK differentiation. We highlight previously unknown secretory properties and provide, for the first time, a comprehensive molecular characterization of CIK cells. Our findings provide a rationale to explore the functional implications and possible therapeutic modulation of CIK secretome.

Original languageEnglish
Pages (from-to)235-246
Number of pages12
JournalMolecular Medicine
Volume23
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Cytokine-Induced Killer Cells
Interleukin-1
Cytokines
Interleukin-15
Interleukin-13
Interleukin-17
Chemokine CCL2
Interleukin-5
Granulocyte-Macrophage Colony-Stimulating Factor
T-Lymphocytes
Interleukin-8
Chemokines
Interleukin-10
Vascular Endothelial Growth Factor A
Interleukin-6
Blood Cells
Interleukin-9
Adoptive Immunotherapy
Interleukin-7
Interleukins

Keywords

  • Adoptive immunotherapy
  • Aglietta
  • Antitumor activity
  • Bianchi
  • Chillemi
  • Cytokine-induced killer (CIK) cells
  • Ferrari
  • Fiorino
  • Gambari
  • Grignani
  • Lampronti
  • Malavasi
  • Manfredini
  • Mesiano
  • Montagner
  • Sangiolo
  • Zini

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Mesiano, G., Zini, R., Montagner, G., Bianchi, N., Manfredini, R., Chillemi, A., ... Ferrari, D. (2017). Analytic and dynamic secretory profile of patient-derived cytokine-induced killer cells. Molecular Medicine, 23, 235-246. https://doi.org/10.2119/molmed.2017.00084

Analytic and dynamic secretory profile of patient-derived cytokine-induced killer cells. / Mesiano, Giulia; Zini, Roberta; Montagner, Giulia; Bianchi, Nicoletta; Manfredini, Rossella; Chillemi, Antonella; Aglietta, Massimo; Grignani, Giovanni; Lampronti, Ilaria; Fiorino, Erika; Malavasi, Fabio; Sangiolo, Dario; Gambari, Roberto; Ferrari, Davide.

In: Molecular Medicine, Vol. 23, 01.01.2017, p. 235-246.

Research output: Contribution to journalArticle

Mesiano, G, Zini, R, Montagner, G, Bianchi, N, Manfredini, R, Chillemi, A, Aglietta, M, Grignani, G, Lampronti, I, Fiorino, E, Malavasi, F, Sangiolo, D, Gambari, R & Ferrari, D 2017, 'Analytic and dynamic secretory profile of patient-derived cytokine-induced killer cells', Molecular Medicine, vol. 23, pp. 235-246. https://doi.org/10.2119/molmed.2017.00084
Mesiano G, Zini R, Montagner G, Bianchi N, Manfredini R, Chillemi A et al. Analytic and dynamic secretory profile of patient-derived cytokine-induced killer cells. Molecular Medicine. 2017 Jan 1;23:235-246. https://doi.org/10.2119/molmed.2017.00084
Mesiano, Giulia ; Zini, Roberta ; Montagner, Giulia ; Bianchi, Nicoletta ; Manfredini, Rossella ; Chillemi, Antonella ; Aglietta, Massimo ; Grignani, Giovanni ; Lampronti, Ilaria ; Fiorino, Erika ; Malavasi, Fabio ; Sangiolo, Dario ; Gambari, Roberto ; Ferrari, Davide. / Analytic and dynamic secretory profile of patient-derived cytokine-induced killer cells. In: Molecular Medicine. 2017 ; Vol. 23. pp. 235-246.
@article{e25b27914ced43f2b8c1583b09b33c19,
title = "Analytic and dynamic secretory profile of patient-derived cytokine-induced killer cells",
abstract = "Adoptive immunotherapy with cytokine induced killer (CIK) cells has shown antitumor activity against several kinds of cancer in preclinical models and clinical trials. CIK cells are a subset of ex vivo expanded T lymphocytes with T-NK phenotype and MHC-unrestricted antitumor activity. The literature provides scant information on cytokines, chemokines and growth factors secreted by CIK cells. Therefore, we investigated the secretory profile of CIK cells generated from tumor patients. The secretome analysis was performed at specific time points (d 1, d 14 and d 21) of CIK cell expansion. Mature CIK cells (d 21) produce a great variety of interleukins and secreted proteins that can be divided into three groups based on their secretion quantity: high (interleukin [IL]-13, regulated on activation normal T cell expressed and secreted [RANTES] chemokine, MIP-1α and 1β), medium (IL-1Ra, IL-5, IL-8, IL-10, IL-17, IP-10, INF-γ, vascular endothelial growth factor [VEGF] and granulocyte-macrophage colony-stimulating factor [GM-CSF]) and low (IL-1β, IL-4, IL-6, IL-7, IL-9, IL-12, IL-15, eotaxin, platelet-derived growth factor-bb, basic fibroblast growth factor, G-CSF and monocyte chemoattractant protein [MCP]-1). Moreover, comparing peripheral blood mononuclear cells (PBMCs) (d 1) and mature CIK cells (d 14 and 21) secretomes, we observed that IL-5, IL-10, IL-13, GM-CSF and VEGF were greatly upregulated, while IL-1β, IL-6, IL-8, IL-15, IL-17, eotaxin, MCP-1 and RANTES were downregulated. We also performed a gene expression profile analysis of patient-derived CIK cells, showing that mRNA for the different cytokines and secreted proteins was modulated during PBMC-to-CIK differentiation. We highlight previously unknown secretory properties and provide, for the first time, a comprehensive molecular characterization of CIK cells. Our findings provide a rationale to explore the functional implications and possible therapeutic modulation of CIK secretome.",
keywords = "Adoptive immunotherapy, Aglietta, Antitumor activity, Bianchi, Chillemi, Cytokine-induced killer (CIK) cells, Ferrari, Fiorino, Gambari, Grignani, Lampronti, Malavasi, Manfredini, Mesiano, Montagner, Sangiolo, Zini",
author = "Giulia Mesiano and Roberta Zini and Giulia Montagner and Nicoletta Bianchi and Rossella Manfredini and Antonella Chillemi and Massimo Aglietta and Giovanni Grignani and Ilaria Lampronti and Erika Fiorino and Fabio Malavasi and Dario Sangiolo and Roberto Gambari and Davide Ferrari",
year = "2017",
month = "1",
day = "1",
doi = "10.2119/molmed.2017.00084",
language = "English",
volume = "23",
pages = "235--246",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",

}

TY - JOUR

T1 - Analytic and dynamic secretory profile of patient-derived cytokine-induced killer cells

AU - Mesiano, Giulia

AU - Zini, Roberta

AU - Montagner, Giulia

AU - Bianchi, Nicoletta

AU - Manfredini, Rossella

AU - Chillemi, Antonella

AU - Aglietta, Massimo

AU - Grignani, Giovanni

AU - Lampronti, Ilaria

AU - Fiorino, Erika

AU - Malavasi, Fabio

AU - Sangiolo, Dario

AU - Gambari, Roberto

AU - Ferrari, Davide

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Adoptive immunotherapy with cytokine induced killer (CIK) cells has shown antitumor activity against several kinds of cancer in preclinical models and clinical trials. CIK cells are a subset of ex vivo expanded T lymphocytes with T-NK phenotype and MHC-unrestricted antitumor activity. The literature provides scant information on cytokines, chemokines and growth factors secreted by CIK cells. Therefore, we investigated the secretory profile of CIK cells generated from tumor patients. The secretome analysis was performed at specific time points (d 1, d 14 and d 21) of CIK cell expansion. Mature CIK cells (d 21) produce a great variety of interleukins and secreted proteins that can be divided into three groups based on their secretion quantity: high (interleukin [IL]-13, regulated on activation normal T cell expressed and secreted [RANTES] chemokine, MIP-1α and 1β), medium (IL-1Ra, IL-5, IL-8, IL-10, IL-17, IP-10, INF-γ, vascular endothelial growth factor [VEGF] and granulocyte-macrophage colony-stimulating factor [GM-CSF]) and low (IL-1β, IL-4, IL-6, IL-7, IL-9, IL-12, IL-15, eotaxin, platelet-derived growth factor-bb, basic fibroblast growth factor, G-CSF and monocyte chemoattractant protein [MCP]-1). Moreover, comparing peripheral blood mononuclear cells (PBMCs) (d 1) and mature CIK cells (d 14 and 21) secretomes, we observed that IL-5, IL-10, IL-13, GM-CSF and VEGF were greatly upregulated, while IL-1β, IL-6, IL-8, IL-15, IL-17, eotaxin, MCP-1 and RANTES were downregulated. We also performed a gene expression profile analysis of patient-derived CIK cells, showing that mRNA for the different cytokines and secreted proteins was modulated during PBMC-to-CIK differentiation. We highlight previously unknown secretory properties and provide, for the first time, a comprehensive molecular characterization of CIK cells. Our findings provide a rationale to explore the functional implications and possible therapeutic modulation of CIK secretome.

AB - Adoptive immunotherapy with cytokine induced killer (CIK) cells has shown antitumor activity against several kinds of cancer in preclinical models and clinical trials. CIK cells are a subset of ex vivo expanded T lymphocytes with T-NK phenotype and MHC-unrestricted antitumor activity. The literature provides scant information on cytokines, chemokines and growth factors secreted by CIK cells. Therefore, we investigated the secretory profile of CIK cells generated from tumor patients. The secretome analysis was performed at specific time points (d 1, d 14 and d 21) of CIK cell expansion. Mature CIK cells (d 21) produce a great variety of interleukins and secreted proteins that can be divided into three groups based on their secretion quantity: high (interleukin [IL]-13, regulated on activation normal T cell expressed and secreted [RANTES] chemokine, MIP-1α and 1β), medium (IL-1Ra, IL-5, IL-8, IL-10, IL-17, IP-10, INF-γ, vascular endothelial growth factor [VEGF] and granulocyte-macrophage colony-stimulating factor [GM-CSF]) and low (IL-1β, IL-4, IL-6, IL-7, IL-9, IL-12, IL-15, eotaxin, platelet-derived growth factor-bb, basic fibroblast growth factor, G-CSF and monocyte chemoattractant protein [MCP]-1). Moreover, comparing peripheral blood mononuclear cells (PBMCs) (d 1) and mature CIK cells (d 14 and 21) secretomes, we observed that IL-5, IL-10, IL-13, GM-CSF and VEGF were greatly upregulated, while IL-1β, IL-6, IL-8, IL-15, IL-17, eotaxin, MCP-1 and RANTES were downregulated. We also performed a gene expression profile analysis of patient-derived CIK cells, showing that mRNA for the different cytokines and secreted proteins was modulated during PBMC-to-CIK differentiation. We highlight previously unknown secretory properties and provide, for the first time, a comprehensive molecular characterization of CIK cells. Our findings provide a rationale to explore the functional implications and possible therapeutic modulation of CIK secretome.

KW - Adoptive immunotherapy

KW - Aglietta

KW - Antitumor activity

KW - Bianchi

KW - Chillemi

KW - Cytokine-induced killer (CIK) cells

KW - Ferrari

KW - Fiorino

KW - Gambari

KW - Grignani

KW - Lampronti

KW - Malavasi

KW - Manfredini

KW - Mesiano

KW - Montagner

KW - Sangiolo

KW - Zini

UR - http://www.scopus.com/inward/record.url?scp=85032452914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032452914&partnerID=8YFLogxK

U2 - 10.2119/molmed.2017.00084

DO - 10.2119/molmed.2017.00084

M3 - Article

AN - SCOPUS:85032452914

VL - 23

SP - 235

EP - 246

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

ER -